Loading...

URGN UROGEN PHARMA LTD Management Changes 8-K Filing

RGN

RGN

UROGEN PHARMA LTD

(URGN)

2024 8-K

Show Summary

Show Summary

New Product Launches

Financial Statements

Financial Results

Asset Acquisition

Investor Presentation

Financial Results

Director Resignation

Financial Results

Annual Meeting Approval

Public Offering

Positive Data from Phase 3 ...

Financial Results Announcement

Financial Results Announcement

Presentation at Conference

Notice of ANDA Submission

Agreement and Phase 3 Study

Amendment to Manufacturing ...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Private Placement

Financial Results Announcement

External Links:

UroGen Pharma Ltd. held its 2024 Annual Meeting of Shareholders, where shareholders approved the 2024 Compensation Policy and an amendment to the 2017 Equity Incentive Plan.

AI Assistant

UROGEN PHARMA LTD

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.